Evidence map›Paper›PMID 39968955›Full record

ArticleProtein science : a publication of the Protein Society2025

Guide to the structural characterization of protein aggregates and amyloid fibrils by CD spectroscopy.

József Kardos, Márton Péter Nyiri, Éva Moussong, Frank Wien, Tamás Molnár, Nikoletta Murvai, Vilmos Tóth, Henrietta Vadászi, Judit Kun, Frédéric Jamme and 1 more

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Peculiarities of the Interaction of the Bacteriolytic Protease Blp fromInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Improving the solubility of single domain antibodies using VH-like hallmark residues.Protein science : a publication of the Protein Society · 2025
    Article
  20. Experimental methods for studying amyloid cross-interactions.Protein science : a publication of the Protein Society · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

József KardosDepartment of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.ORCID 0000-0002-2135-2932
Márton Péter NyiriDepartment of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Éva MoussongDepartment of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Frank WienDISCO Beamline, Synchrotron SOLEIL, Gif-sur-Yvette, France.ORCID 0000-0002-0752-8735
Tamás MolnárDepartment of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Nikoletta MurvaiDepartment of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Vilmos TóthELTE NAP Neuroimmunology Research Group, Department of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Henrietta VadásziDepartment of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Judit KunDepartment of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Frédéric JammeDISCO Beamline, Synchrotron SOLEIL, Gif-sur-Yvette, France.
András MicsonaiDepartment of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.

Funding

Eötvös Loránd TudományegyetemEötvös Loránd University Excellence FundHungarian Academy of SciencesMagyar Tudományos AkadémiaNational Research, Development, and Innovation FundNemzeti Kutatási Fejlesztési és Innovációs HivatalRichter Gedeon Talentum Alapítvány
6 · The paper itself

Abstract

Protein aggregation and amyloid formation are linked to numerous degenerative diseases, such as Alzheimer's or Parkinson's disease. Additionally, protein aggregation plays a crucial role in various biological processes, such as storage of molecules or cell signaling. Protein molecules can form a wide range of aggregates, from oligomers of different sizes to non-specific aggregates and highly ordered cross-β structured amyloid fibrils with diverse morphologies. Circular dichroism (CD) spectroscopy is a widely used technique to study protein structures providing detailed information at the secondary structure level, and is ideal to distinguish and characterize protein aggregates. Despite its potential, CD spectroscopy is often perceived as having limited application on protein aggregates due to challenges, such as sample inhomogeneity, precipitation, light scattering and other factors that complicate accurate analysis. In this study, we present a detailed protocol for examining the structure of protein aggregates and amyloid fibrils using CD spectroscopy. We outline the optimal experimental conditions for sample preparation and demonstrate how to identify and mitigate various interfering effects, using specific examples of disease-related amyloidogenic proteins. We also discuss the instrumental parameters, baseline subtraction, normalization, and quality control of CD spectra. Furthermore, we evaluate the performance of different secondary structure estimating algorithms on amyloid fibril CD spectra highlighting the superiority of BeStSel and CDNN. Our findings could enhance the structural analysis of protein aggregates, contributing to a better understanding of associated diseases and the development of new therapeutic strategies.

Indexed as

AmyloidCircular DichroismProtein AggregatesAnimalsHumansProtein ConformationAmyloidProtein AggregatesAlzheimer's diseaseamyloid formationamyloid‐βBeStSelcircular dichroism spectroscopyprotein aggregationsecondary structure estimation

Identifiers

PMID39968955
PMCPMC11836901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.